Stay updated with breaking news from Xiaobin Wu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BeiGene (NASDAQ:BGNE – Free Report) had its price target cut by Morgan Stanley from $321.00 to $319.00 in a research note released on Tuesday, Benzinga reports. They currently have an overweight rating on the stock. A number of other analysts have also weighed in on BGNE. 22nd Century Group reaffirmed a downgrade rating on shares […]
StockNews.com started coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a report published on Thursday morning. The brokerage issued a hold rating on the stock. Other equities analysts have also recently issued reports about the stock. JPMorgan Chase & Co. raised their target price on shares of BeiGene from $297.00 to $300.00 and […]
Equities researchers at Jefferies Financial Group started coverage on shares of BeiGene (NASDAQ:BGNE – Get Free Report) in a research report issued on Thursday, MarketBeat.com reports. The firm set a “buy” rating and a $287.00 price target on the stock. Jefferies Financial Group’s price objective points to a potential upside of 49.22% from the company’s […]
BeiGene (NASDAQ:BGNE – Get Free Report) posted its quarterly earnings data on Wednesday. The company reported ($3.64) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.47) by ($0.17), Briefing.com reports. BeiGene had a negative net margin of 123.48% and a negative return on equity of 41.58%. The business had revenue of […]
BeiGene, Ltd. (NASDAQ:BGNE – Get Free Report) has been given an average rating of “Moderate Buy” by the nine brokerages that are covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month target price among brokers […]